What were Chandan Healthcare Ltd's latest quarterly results?
Chandan Healthcare Ltd's latest quarterly results (Dec 2025) show
- PAT Growth YoY: +8.1%
- Revenue Growth YoY: +19.0%
- Operating Margin: 18.2%
Chandan Healthcare Ltd (Diagnostic Services) — fundamental analysis, earnings data, and key metrics. PE: 19.5. ROE: 27.1%. This stock is not currently in the Nifty 500 momentum outperformers list.
Based on publicly available financial data. This is educational research, not investment advice.
Chandan Healthcare Ltd's latest quarterly results (Dec 2025) show
Chandan Healthcare Ltd's current PE ratio is 19.5x.
Chandan Healthcare Ltd's price-to-book ratio is 4.1x.
Chandan Healthcare Ltd's fundamental strength based on key financial ratios
Chandan Healthcare Ltd has a debt-to-equity ratio of N/A.
Chandan Healthcare Ltd's return ratios over recent years
Chandan Healthcare Ltd's operating cash flow is negative (FY2025).
Chandan Healthcare Ltd currently does not pay a significant dividend (yield 0.00%).
Chandan Healthcare Ltd's shareholding pattern (Dec 2025)
Chandan Healthcare Ltd's promoter holding has remained stable recently.
Chandan Healthcare Ltd is an established outperformer with 1 weeks of consecutive Nifty 500 outperformance.
Based on quantitative research signals, here is why Chandan Healthcare Ltd may be worth studying
Chandan Healthcare Ltd investment thesis summary:
Chandan Healthcare Ltd's forward outlook based on current data signals
The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.